Biomerica (BMRA) Equity Average (2011 - 2026)

Biomerica's Equity Average history runs 16 years deep, the most recent figure standing at $3.9 million for Q1 2026.

• In Q1 2026, Equity Average fell 27.2% year-over-year to $3.9 million; the TTM figure through Feb 2026 stood at $3.9 million (down 27.2% YoY), while the FY2025 annual figure was $5.3 million, down 41.6% from the prior year.
• Equity Average came in at $3.9 million for Q1 2026 at Biomerica, down from $4.8 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $11.2 million in Q3 2023 to a low of $3.9 million in Q1 2026.
• A 5-year average of $7.2 million and a median of $7.2 million in 2024 frame the typical range for Equity Average.
• Across the five-year window, Equity Average surged 35.11% in 2023 and sank 48.09% in 2024, its largest moves.
• Biomerica's Equity Average stood at $7.8 million in 2022, then rose by 29.46% to $10.1 million in 2023, then tumbled by 48.09% to $5.2 million in 2024, then decreased by 8.32% to $4.8 million in 2025, then retreated by 19.17% to $3.9 million in 2026.
• According to Business Quant data, Equity Average over the past three periods registered $3.9 million, $4.8 million, and $4.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison